Japan's development assistance for health: Historical trends and prospects for a new era
Summary: The year 2020 marked an important turning point in Japan's global health policy. While the global health community has been suffering serious damage to sustainable health financing due to the COVID-19 pandemic, an independent commission on Japan's Strategy on Development Assistance for Health (DAH) launched an ambitious policy recommendation to double the amount of Japan's DAH during the post-COVID-19 era. This paper examines historical trends in DAH in Japan over the past 30 years based on published literature and comprehensive DAH tracking data and highlights priority areas for discussion on how DAH can be advanced to ensure equitable and efficient use of limited resources to support the achievement of the Sustainable Development Goals, including universal health coverage and pandemic preparedness, in low- and middle-income countries. Priority areas for discussion include: how and where to focus DAH for equitable health gains; how to provide DAH to support health system strengthening, including pandemic preparedness; and clarifying the role of DAH in global health functions..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
The Lancet Regional Health. Western Pacific - 22(2022), Seite 100403- |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shuhei Nomura [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Development assistance for health |
|---|
| doi: |
10.1016/j.lanwpc.2022.100403 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ074774212 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ074774212 | ||
| 003 | DE-627 | ||
| 005 | 20230502090257.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lanwpc.2022.100403 |2 doi | |
| 035 | |a (DE-627)DOAJ074774212 | ||
| 035 | |a (DE-599)DOAJ93a7ba1afaae4af3bc7bcbba94ead751 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RA1-1270 | |
| 100 | 0 | |a Shuhei Nomura |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Japan's development assistance for health: Historical trends and prospects for a new era |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Summary: The year 2020 marked an important turning point in Japan's global health policy. While the global health community has been suffering serious damage to sustainable health financing due to the COVID-19 pandemic, an independent commission on Japan's Strategy on Development Assistance for Health (DAH) launched an ambitious policy recommendation to double the amount of Japan's DAH during the post-COVID-19 era. This paper examines historical trends in DAH in Japan over the past 30 years based on published literature and comprehensive DAH tracking data and highlights priority areas for discussion on how DAH can be advanced to ensure equitable and efficient use of limited resources to support the achievement of the Sustainable Development Goals, including universal health coverage and pandemic preparedness, in low- and middle-income countries. Priority areas for discussion include: how and where to focus DAH for equitable health gains; how to provide DAH to support health system strengthening, including pandemic preparedness; and clarifying the role of DAH in global health functions. | ||
| 650 | 4 | |a Japan | |
| 650 | 4 | |a Development assistance for health | |
| 650 | 4 | |a Health system strengthening | |
| 650 | 4 | |a Non-communicable diseases | |
| 650 | 4 | |a Disease burden | |
| 650 | 4 | |a National income | |
| 653 | 0 | |a Public aspects of medicine | |
| 700 | 0 | |a Lisa Yamasaki |e verfasserin |4 aut | |
| 700 | 0 | |a Kazuki Shimizu |e verfasserin |4 aut | |
| 700 | 0 | |a Cyrus Ghaznavi |e verfasserin |4 aut | |
| 700 | 0 | |a Haruka Sakamoto |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t The Lancet Regional Health. Western Pacific |d Elsevier, 2021 |g 22(2022), Seite 100403- |w (DE-627)DOAJ078609631 |x 26666065 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g pages:100403- |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.lanwpc.2022.100403 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/93a7ba1afaae4af3bc7bcbba94ead751 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S2666606522000189 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2666-6065 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |h 100403- | ||